Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)
Close on Nov 17, 2026Market cap $3.17BP/E –Yield –
Bausch Health Companies cash
Cash and short-term investments held at the end of each period.
Bausch Health Companies's cash was $2.49B at Sep 30, 2026. For fiscal 2025 it was $1.31B, up 9.0% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $3.24B in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.31B | +9.0% |
| FY2024 | Dec 31, 2024 | $1.20B | +26.8% |
| FY2023 | Dec 31, 2023 | $947.00M | +60.2% |
| FY2022 | Dec 31, 2022 | $591.00M | -72.1% |
| FY2021 | Dec 31, 2021 | $2.12B | +16.7% |
| FY2020 | Dec 31, 2020 | $1.82B | -44.0% |
| FY2019 | Dec 31, 2019 | $3.24B | +349.9% |
| FY2018 | Dec 31, 2018 | $721.00M | -9.5% |
| FY2017 | Dec 31, 2017 | $797.00M | +47.0% |
| FY2016 | Dec 31, 2016 | $542.00M | -9.2% |
| FY2015 | Dec 31, 2015 | $597.00M | +84.8% |
| FY2014 | Dec 31, 2014 | $323.00M | -46.2% |
| FY2013 | Dec 31, 2013 | $600.00M | -34.8% |
| FY2012 | Dec 31, 2012 | $920.51M | +440.1% |
| FY2011 | Dec 31, 2011 | $170.44M | -57.4% |
| FY2010 | Dec 31, 2010 | $400.35M | +222.8% |
| FY2009 | Dec 31, 2009 | $124.03M | -60.9% |
| FY2008 | Dec 31, 2008 | $317.55M | -26.8% |
| FY2007 | Dec 31, 2007 | $433.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.49B | +90.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.83B | +5.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.30B | +14.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.31B | +9.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.31B | +81.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.73B | +190.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.13B | +54.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.20B | +26.8% |
| Q3 FY2024 | Sep 30, 2024 | $719.00M | -5.4% |
| Q2 FY2024 | Jun 30, 2024 | $595.00M | +2.8% |
| Q1 FY2024 | Mar 31, 2024 | $733.00M | +41.5% |
| Q4 FY2023 | Dec 31, 2023 | $947.00M | +60.2% |
| Q3 FY2023 | Sep 30, 2023 | $760.00M | +56.4% |
| Q2 FY2023 | Jun 30, 2023 | $579.00M | -12.1% |
| Q1 FY2023 | Mar 31, 2023 | $518.00M | -58.5% |
| Q4 FY2022 | Dec 31, 2022 | $591.00M | -72.1% |
| Q3 FY2022 | Sep 30, 2022 | $486.00M | -29.6% |
| Q2 FY2022 | Jun 30, 2022 | $659.00M | +2.6% |
| Q1 FY2022 | Mar 31, 2022 | $1.25B | +83.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.12B | +16.7% |
| Q3 FY2021 | Sep 30, 2021 | $690.00M | -29.4% |
| Q2 FY2021 | Jun 30, 2021 | $642.00M | -28.3% |
| Q1 FY2021 | Mar 31, 2021 | $679.00M | -25.5% |
| Q4 FY2020 | Dec 31, 2020 | $1.82B | -44.0% |
| Q3 FY2020 | Sep 30, 2020 | $977.00M | +18.4% |
| Q2 FY2020 | Jun 30, 2020 | $896.00M | +2.1% |
| Q1 FY2020 | Mar 31, 2020 | $912.00M | +16.6% |
| Q4 FY2019 | Dec 31, 2019 | $3.24B | +349.9% |
| Q3 FY2019 | Sep 30, 2019 | $825.00M | -15.2% |
| Q2 FY2019 | Jun 30, 2019 | $878.00M | +4.8% |
| Q1 FY2019 | Mar 31, 2019 | $782.00M | -14.0% |
| Q4 FY2018 | Dec 31, 2018 | $721.00M | -9.5% |
| Q3 FY2018 | Sep 30, 2018 | $973.00M | +0.9% |
| Q2 FY2018 | Jun 30, 2018 | $838.00M | -31.0% |
| Q1 FY2018 | Mar 31, 2018 | $909.00M | -24.9% |
| Q4 FY2017 | Dec 31, 2017 | $797.00M | +47.0% |
| Q3 FY2017 | Sep 30, 2017 | $964.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.21B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.21B | – |
| Q4 FY2016 | Dec 31, 2016 | $542.00M | – |
See a number that looks wrong?